FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4281744239> ?p ?o ?g. }

• W4281744239 endingPage "2609" @default.
• W4281744239 startingPage "2601" @default.
• W4281744239 abstract "Abstract Aims No study has evaluated the prognostic value of the chronic kidney disease (CKD) classification by cystatin C‐based estimated glomerular filtration rate (eGFR) (CKD Cys classification) in patients undergoing transcatheter aortic valve replacement (TAVR). This study aimed to compare the prognostic value of CKD Cys classification and CKD classification by creatinine‐based eGFR (CKD Cr classification) in risk prediction after TAVR. Methods and results We retrospectively analysed consecutive 219 patients with symptomatic severe aortic stenosis who underwent TAVR at our institute between December 2016 and June 2019. Pre‐operative CKD Cr and CKD Cys classifications were evaluated for their prognostic value of 2‐year major adverse cardiovascular and cerebrovascular events (MACCE) after TAVR. MACCE was defined as the composite of all‐cause mortality, non‐fatal myocardial infarction, stroke, and rehospitalization for worsening congestive heart failure. Participants had a median age of 86.0 years and were predominantly female (76.9%). In 96.6% of the cases, TAVR was performed using transfemoral access. The median creatinine‐based eGFR (52.85 mL/min/1.73 m 2 ) was higher than the cystatin C‐based eGFR (41.50 mL/min/1.73 m 2 ). Downward reclassification in CKD stages based on eGFR Cys was observed in 49.0% of patients. During a median follow‐up period of 575.5 (interquartile range: 367.0–730.0) days, 58 patients presented with MACCE. CKD Cys classification, but not CKD Cr classification, significantly stratified the risk of 2‐year MACCE in patients after TAVR by log‐rank test ( P = 0.003). In multivariate Cox regression analysis, only CKD Cys stage 3b [hazard ratio (HR) = 4.37; 95% confidence interval (CI): 1.28–14.91; P = 0.019] and CKD Cys stage 4 + 5 (HR = 3.72; 95% CI: 1.06–12.99; P = 0.040) were significant predictors of MACCE after adjustment for potential confounders. Conclusions The CKD Cys classification could better assess the risk than the CKD Cr classification in patients undergoing TAVR. CKD Cys stage 3b and stage 4 + 5 correlated with adverse outcomes." @default.
• W4281744239 created "2022-06-13" @default.
• W4281744239 creator A5002965704 @default.
• W4281744239 creator A5005527758 @default.
• W4281744239 creator A5006054960 @default.
• W4281744239 creator A5013110557 @default.
• W4281744239 creator A5024009138 @default.
• W4281744239 creator A5031967502 @default.
• W4281744239 creator A5047689921 @default.
• W4281744239 creator A5060283981 @default.
• W4281744239 creator A5069721977 @default.
• W4281744239 creator A5080267837 @default.
• W4281744239 creator A5083300175 @default.
• W4281744239 date "2022-06-06" @default.
• W4281744239 modified "2023-09-30" @default.
• W4281744239 title "Cystatin C in risk prediction after transcatheter aortic valve replacement: a retrospective analysis" @default.
• W4281744239 cites W143080477 @default.
• W4281744239 cites W2010520337 @default.
• W4281744239 cites W2011632129 @default.
• W4281744239 cites W2019827464 @default.
• W4281744239 cites W2044400770 @default.
• W4281744239 cites W2045181376 @default.
• W4281744239 cites W2077641457 @default.
• W4281744239 cites W2113760558 @default.
• W4281744239 cites W2117051020 @default.
• W4281744239 cites W2123775770 @default.
• W4281744239 cites W2131679501 @default.
• W4281744239 cites W2139087994 @default.
• W4281744239 cites W2145632027 @default.
• W4281744239 cites W2155965977 @default.
• W4281744239 cites W2166027867 @default.
• W4281744239 cites W2515126756 @default.
• W4281744239 cites W2607031541 @default.
• W4281744239 cites W2617693595 @default.
• W4281744239 cites W2765162354 @default.
• W4281744239 cites W2801953332 @default.
• W4281744239 cites W2913468385 @default.
• W4281744239 cites W2980673459 @default.
• W4281744239 cites W3042331661 @default.
• W4281744239 cites W3043521565 @default.
• W4281744239 cites W3047242388 @default.
• W4281744239 cites W4205565352 @default.
• W4281744239 cites W4281744239 @default.
• W4281744239 doi "https://doi.org/10.1002/ehf2.13977" @default.
• W4281744239 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35661440" @default.
• W4281744239 hasPublicationYear "2022" @default.
• W4281744239 type Work @default.
• W4281744239 citedByCount "2" @default.
• W4281744239 countsByYear W42817442392022 @default.
• W4281744239 countsByYear W42817442392023 @default.
• W4281744239 crossrefType "journal-article" @default.
• W4281744239 hasAuthorship W4281744239A5002965704 @default.
• W4281744239 hasAuthorship W4281744239A5005527758 @default.
• W4281744239 hasAuthorship W4281744239A5006054960 @default.
• W4281744239 hasAuthorship W4281744239A5013110557 @default.
• W4281744239 hasAuthorship W4281744239A5024009138 @default.
• W4281744239 hasAuthorship W4281744239A5031967502 @default.
• W4281744239 hasAuthorship W4281744239A5047689921 @default.
• W4281744239 hasAuthorship W4281744239A5060283981 @default.
• W4281744239 hasAuthorship W4281744239A5069721977 @default.
• W4281744239 hasAuthorship W4281744239A5080267837 @default.
• W4281744239 hasAuthorship W4281744239A5083300175 @default.
• W4281744239 hasBestOaLocation W42817442392 @default.
• W4281744239 hasConcept C119060515 @default.
• W4281744239 hasConcept C126322002 @default.
• W4281744239 hasConcept C127413603 @default.
• W4281744239 hasConcept C159641895 @default.
• W4281744239 hasConcept C164705383 @default.
• W4281744239 hasConcept C167135981 @default.
• W4281744239 hasConcept C2778198053 @default.
• W4281744239 hasConcept C2778653478 @default.
• W4281744239 hasConcept C2779548226 @default.
• W4281744239 hasConcept C2780007028 @default.
• W4281744239 hasConcept C2780026749 @default.
• W4281744239 hasConcept C2780306776 @default.
• W4281744239 hasConcept C2780645631 @default.
• W4281744239 hasConcept C2781414266 @default.
• W4281744239 hasConcept C500558357 @default.
• W4281744239 hasConcept C71924100 @default.
• W4281744239 hasConcept C78519656 @default.
• W4281744239 hasConceptScore W4281744239C119060515 @default.
• W4281744239 hasConceptScore W4281744239C126322002 @default.
• W4281744239 hasConceptScore W4281744239C127413603 @default.
• W4281744239 hasConceptScore W4281744239C159641895 @default.
• W4281744239 hasConceptScore W4281744239C164705383 @default.
• W4281744239 hasConceptScore W4281744239C167135981 @default.
• W4281744239 hasConceptScore W4281744239C2778198053 @default.
• W4281744239 hasConceptScore W4281744239C2778653478 @default.
• W4281744239 hasConceptScore W4281744239C2779548226 @default.
• W4281744239 hasConceptScore W4281744239C2780007028 @default.
• W4281744239 hasConceptScore W4281744239C2780026749 @default.
• W4281744239 hasConceptScore W4281744239C2780306776 @default.
• W4281744239 hasConceptScore W4281744239C2780645631 @default.
• W4281744239 hasConceptScore W4281744239C2781414266 @default.
• W4281744239 hasConceptScore W4281744239C500558357 @default.
• W4281744239 hasConceptScore W4281744239C71924100 @default.
• W4281744239 hasConceptScore W4281744239C78519656 @default.
• W4281744239 hasIssue "4" @default.

• next